Loading...
Sold out
SAME 200mg 60vcap - Agora Alimentos
€59,90 EUR
Unit price
/
Unavailable
SAME 200mg 60vcap - Agora Alimentos is backordered and will ship as soon as it is back in stock.
Description
Description
SAME 200mg Now supports the Nervous System and helps regulate mood and mood.
SAM-e (S-adenosyl-L-methionine) is found in all cells and body fluids, where it participates as a methyl group donor in more than 40 biochemical reactions in the body.
Over the past two decades, numerous studies have shown that NOW 's SAM-e is effective in treating depression, osteoarthritis, and liver disease. Furthermore, SAM-e has a very favorable side effect profile compared to standard medications.
It has an antidepressant effect by stimulating the metabolism of monoamine (dopamine, norepinephrine, epinephrine and serotonin).
Clinical studies conducted in 1973 indicated that SAMe had antidepressant effects. Over the next two decades, SAMe's efficacy in treating depressive disorders was confirmed in more than 40 clinical trials. A meta-analysis showed that SAMe had a significantly higher response rate than placebo and was comparable to tricyclic antidepressants.
The antidepressant effect of SAM-e is of particular interest due to its close metabolic relationship with folate and the association of a high incidence of folate deficiency with depression.
The potential benefit of SAM-e in the treatment of osteoarthritis was discovered when patients enrolled in clinical trials of SAM-e for depression reported a marked improvement in their symptoms. Nine clinical trials in Europe and one in the United States, with a total of over 22,000 participants, confirmed SAM-e's therapeutic activity against osteoarthritis. In other words, it has effects similar to those of nonsteroidal anti-inflammatory drugs, but is more tolerable.
60 vegetable capsules
SAME 200mg Now supports the Nervous System and helps regulate mood and mood.
SAM-e (S-adenosyl-L-methionine) is found in all cells and body fluids, where it participates as a methyl group donor in more than 40 biochemical reactions in the body.
Over the past two decades, numerous studies have shown that NOW 's SAM-e is effective in treating depression, osteoarthritis, and liver disease. Furthermore, SAM-e has a very favorable side effect profile compared to standard medications.
It has an antidepressant effect by stimulating the metabolism of monoamine (dopamine, norepinephrine, epinephrine and serotonin).
Clinical studies conducted in 1973 indicated that SAMe had antidepressant effects. Over the next two decades, SAMe's efficacy in treating depressive disorders was confirmed in more than 40 clinical trials. A meta-analysis showed that SAMe had a significantly higher response rate than placebo and was comparable to tricyclic antidepressants.
The antidepressant effect of SAM-e is of particular interest due to its close metabolic relationship with folate and the association of a high incidence of folate deficiency with depression.
The potential benefit of SAM-e in the treatment of osteoarthritis was discovered when patients enrolled in clinical trials of SAM-e for depression reported a marked improvement in their symptoms. Nine clinical trials in Europe and one in the United States, with a total of over 22,000 participants, confirmed SAM-e's therapeutic activity against osteoarthritis. In other words, it has effects similar to those of nonsteroidal anti-inflammatory drugs, but is more tolerable.
60 vegetable capsules
